Yumanity Therapeutics (YMTX) Stock Chart & Stock Price History → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free YMTX Stock Alerts $0.62 +0.06 (+10.62%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media Yumanity Therapeutics Stock Price Performance5 Day Performance+5.95%1 Month Performance+45.35%3 Month Performance-76.24%6 Month Performance-84.30%Year-To-Date Performance-82.78%1 Year Performance-84.38% Receive YMTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yumanity Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> YMTX Stock Chart for Friday, May, 10, 2024 YMTX Chart by TradingView Yumanity Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$0.58$0.63+8.43%$0.65$0.53292,443 shs$6.79 million05/08/2024$0.58$0.58$0.61$0.5736,586 shs$6.26 million05/07/2024$0.59$0.58-2.29%$0.61$0.5736,578 shs$6.26 million05/06/2024$0.59$0.59$0.61$0.5367,152 shs$6.40 million05/03/2024$0.56$0.59+5.15%$0.61$0.5367,152 shs$6.40 million05/02/2024$0.55$0.56+1.81%$0.58$0.5056,753 shs$6.09 million Get the Latest News and Ratings for YMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Yumanity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$0.56$0.55-2.37%$0.62$0.55157,067 shs$5.98 million04/30/2024$0.59$0.56-3.60%$0.63$0.5463,269 shs$6.13 million04/29/2024$0.61$0.59-4.02%$0.61$0.5928,568 shs$6.36 million04/26/2024$0.62$0.61-1.61%$0.62$0.57130,623 shs$6.62 million04/25/2024$0.62$0.62$0.67$0.60172,767 shs$6.73 million04/24/2024$0.63$0.62-2.35%$0.67$0.60172,143 shs$6.73 million04/23/2024$0.63$0.63$0.74$0.51832,435 shs$6.89 million04/22/2024$0.53$0.63+20.47%$0.74$0.51818,607 shs$6.89 million04/19/2024$0.49$0.53+8.41%$0.55$0.49478,877 shs$5.72 million04/18/2024$0.47$0.49+3.43%$0.55$0.41838,282 shs$5.28 million04/17/2024$0.48$0.47-2.02%$0.52$0.42729,932 shs$5.10 million04/16/2024$0.34$0.48+41.09%$0.55$0.335.35 million shs$5.21 million04/15/2024$0.36$0.34-6.34%$0.39$0.34164,078 shs$3.69 million04/12/2024$0.44$0.44$0.47$0.37568,387 shs$4.78 million04/11/2024$0.37$0.44+18.92%$0.47$0.37555,284 shs$4.78 million04/10/2024$0.43$0.37-13.95%$0.43$0.35430,637 shs$4.02 million04/09/2024$0.56$0.43-23.20%$0.49$0.411.21 million shs$4.67 million04/08/2024$0.56$0.56$0.59$0.5366,101 shs$6.08 million04/05/2024$0.56$0.56+0.43%$0.59$0.5366,101 shs$6.08 million04/04/2024$0.57$0.56-2.12%$0.60$0.53100,824 shs$6.05 million04/03/2024$0.49$0.57+15.42%$0.57$0.4754,385 shs$6.18 million04/02/2024$0.51$0.49-2.57%$0.53$0.4639,861 shs$5.36 million04/01/2024$0.53$0.51-3.58%$0.53$0.4645,791 shs$5.50 million03/29/2024$0.52$0.53+0.77%$0.57$0.41139,857 shs$5.70 million03/28/2024$0.52$0.52$0.60$0.5199,011 shs$5.66 million03/27/2024$0.56$0.52-6.19%$0.60$0.5198,910 shs$5.66 million03/26/2024$0.56$0.56$0.66$0.49140,641 shs$6.03 million03/25/2024$0.65$0.56-14.49%$0.66$0.49139,851 shs$6.03 million03/22/2024$0.57$0.65+15.03%$0.65$0.5594,129 shs$7.06 million03/21/2024$0.54$0.57+5.25%$0.58$0.5450,315 shs$6.13 million03/20/2024$0.56$0.54-3.59%$0.57$0.5052,782 shs$5.83 million03/19/2024$0.56$0.56$0.63$0.5379,427 shs$6.05 million03/18/2024$0.55$0.56+2.17%$0.63$0.5379,427 shs$6.05 million03/15/2024$0.62$0.61-0.75%$0.62$0.5559,294 shs$6.63 millionForget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details03/14/2024$0.62$0.62$0.64$0.57100,497 shs$6.68 million03/13/2024$0.69$0.62-10.83%$0.64$0.57100,497 shs$6.68 million03/12/2024$0.69$0.69$0.76$0.6687,864 shs$7.49 million03/11/2024$0.70$0.69-0.72%$0.76$0.6687,864 shs$7.49 million03/08/2024$0.78$0.77-1.56%$0.81$0.7493,702 shs$8.34 million03/07/2024$0.78$0.78$0.90$0.76199,339 shs$8.47 million03/06/2024$1.01$0.78-22.75%$0.90$0.76199,315 shs$8.47 million03/05/2024$1.01$1.01$1.33$0.952.11 million shs$10.97 million03/04/2024$0.89$1.01+13.36%$1.33$0.952.08 million shs$10.97 million03/01/2024$2.26$0.89-60.58%$0.97$0.77246,559 shs$9.67 million02/29/2024$2.26$2.26$2.36$2.2627,115 shs$24.54 million02/28/2024$2.32$2.26-2.59%$2.36$2.2627,071 shs$24.54 million02/27/2024$2.32$2.32$2.50$2.3025,380 shs$25.19 million02/26/2024$2.52$2.32-7.94%$2.50$2.3024,273 shs$25.19 million02/23/2024$2.60$2.52-3.08%$2.70$2.4714,258 shs$27.36 million02/22/2024$2.60$2.60$2.68$2.555,531 shs$28.23 million02/21/2024$2.83$2.60-8.13%$2.82$2.6020,171 shs$28.23 million02/20/2024$2.83$2.83$2.83$2.644,475 shs$30.72 million02/19/2024$2.83$2.83$2.83$2.644,475 shs$30.72 million02/16/2024$2.75$2.83+2.91%$2.83$2.644,475 shs$30.72 million02/15/2024$2.62$2.75+4.96%$2.75$2.442,883 shs$29.85 million02/14/2024$2.62$2.62$2.71$2.466,001 shs$28.44 million02/13/2024$2.62$2.62$2.70$2.5512,582 shs$28.44 million02/12/2024$2.63$2.62-0.38%$2.70$2.5512,582 shs$28.44 million02/09/2024$2.51$2.63+4.78%$2.64$2.415,266 shs$28.55 million02/08/2024$2.55$2.51-1.57%$2.61$2.479,629 shs$27.25 million Related Companies: Protagenic Therapeutics Stock Price Chart Kineta Stock Price Chart Kintara Therapeutics Stock Price Chart Processa Pharmaceuticals Stock Price Chart Ainos Stock Price Chart Hoth Therapeutics Stock Price Chart Hillstream BioPharma Stock Price Chart iBio Stock Price Chart Lixte Biotechnology Stock Price Chart Xenetic Biosciences Stock Price Chart Receive YMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Yumanity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YMTX) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yumanity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.